Can Fite (Israel) Price Prediction and Hype Density Breakdown

CANF -- Israel Stock  

ILS 214.60  10.70  5.25%

We analyze noise-free headlines and recent hype associated with Can Fite BioPharma Ltd which may create opportunities for some arbitrage if properly timed. With Can Fite hype-based prediction module you can estimate the value of Can Fite BioPharma Ltd from the prospective of Can Fite response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Can Fite over a specific investment horizon. Check also Trending Equities.
Horizon     30 Days    Login   to change

Can Fite After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Can Fite Estimiated After-Hype Price Volatility

March 25, 2019
Current Value
After-hype Price
Target Odds
Odds Odds
Can Fite is Unknown risk asset. Analysis and calculation of next after-hype price of Can Fite BioPharma is based on 2 months time horizon.

Can Fite Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.03% 2.39% 0.04%  0.35% 3 Events / Month6 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Can Fite Hype Timeline

Can Fite BioPharma is currently traded for 214.60on Tel Aviv Stock Exchange of Israel. The entity has historical hype elasticity of -0.04 and average elasticity to hype of competition of -0.35. Can Fite BioPharma Ltd is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 183.85%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at -0.03%. The volatility of relative hype elasticity to Can Fite is about 20.22%%. The volatility of related hype on Can Fite is about 20.22% with expected price after next announcement by competition of 214.25. The company recorded loss per share of 0.13. Can Fite BioPharma had not issued any dividends in recent years. The entity had a split on 2013-05-12. Assuming 30 trading days horizon, the next anticipated press release will be in about 3 days.
Check also Trending Equities.

Can Fite Related Hype Analysis

Investors are also interested in

Purchased few shares
Active a day ago
Purchased few shares
Active a day ago
Purchased a lot of shares
Active a day ago
Check also Trending Equities. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.